Home Watchlists Portfolios Indices Forex Futures Market Scan Chart Settings

Lipocine Inc. (LPCN)'s Financial Results Comparing With Collegium Pharmaceutical Inc. (NASDAQ:COLL)



  • Source: The NBO News - - Read: 0

    Summary:

     

    We are comparing Lipocine Inc. (NASDAQ:LPCN) and Collegium Pharmaceutical Inc. (NASDAQ:COLL) on their profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. They both are Drugs – Generic companies, competing one another.

    Earnings & Valuation

    Gross Revenue

    Price/Sales Ratio

    Net Income

    Earnings Per Share

    Price/Earnings Ratio

    Lipocine Inc.

    2

    0.00

    N/A

    -0.56

    0.00

    Collegium Pharmaceutical Inc.

    14

    1.25

    N/A

    -0.91

    0.00

    Table 1 shows the gross revenue, earnings per share (EPS) and valuation for Lipocine Inc. and Collegium Pharmaceutical Inc.

    Profitability

    Table 2 has Lipocine Inc. and Collegium Pharmaceutical Inc.’s return on equity, return on assets and net margins.

    Net Margins

    Return on Equity

    Return on Assets

    Lipocin ...

     

     

    Read Full News: https://nbonews.com/lipocine-inc-lpcns-financial-results-comparing-with-collegium-pharmaceutical-inc-nasdaqcoll/


Log in to reply